These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 623439)

  • 21. Tissue polypeptide antigen (TPA): usefulness in urological neoplasia.
    Costello CB; Kumar S
    Anticancer Res; 1986; 6(4):713-6. PubMed ID: 3752950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gc group distributions in patients with cancer.
    Hughes NR
    J Natl Cancer Inst; 1968 Aug; 41(2):303-11. PubMed ID: 4299536
    [No Abstract]   [Full Text] [Related]  

  • 23. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
    Sekikawa K
    Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of five tumor marker assay in patients with lung cancer.
    Mizushima Y; Tsuji H; Izumi S; Hirata H; Kin Y; Kawasaki A; Matsui S; Yano S
    Anticancer Res; 1991; 11(1):91-5. PubMed ID: 2018388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significances of tissue polypeptide antigen in patients with gynecological malignancies].
    Ueda M; Sudo N; Furuya M; Arakawa O; Ikarashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Nov; 37(11):2361-8. PubMed ID: 3001201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Alpha-ketoglutaric acid increase in the blood and the localization and histology of malignant tumors].
    Kronberger L; Fink E
    Med Klin; 1969 Dec; 64(49):2292-6. PubMed ID: 5359279
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical evaluation of serum tissue polypeptide antigen (TPA) in patients with colo-rectal cancer].
    Yukawa H; Kono N; Taniguchi K; Ieda K; Ono K; Yamamoto S; Koh K; Ohta M; Hayashido M; Yamaguchi K
    Nihon Geka Hokan; 1984 Mar; 53(2):433-6. PubMed ID: 6508467
    [No Abstract]   [Full Text] [Related]  

  • 28. Human tissue polypeptide antigen in breast cancer.
    Nemoto T; Constantine R; Chu TM
    J Natl Cancer Inst; 1979 Dec; 63(6):1347-50. PubMed ID: 292806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic predictability of CEA and TPA tumor markers in bronchoalveolar lavage fluid].
    Loos U; Oehr P; Genske F; Schlack W
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():235-7. PubMed ID: 3174571
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity and basis of the tissue polypeptide antigen.
    Björklund B; Björklund V
    Cancer Detect Prev; 1983; 6(1-2):41-50. PubMed ID: 6883392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical usefulness of serum TPA, IAP and CEA levels in gynecological cancer].
    Saitoh S; Nakanishi A; Noda T; Ando Y; Kamamoto Y; Moriyama I; Ichijo M
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1496-504. PubMed ID: 6520506
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
    Kazama T; Katayama T; Yamazaki N
    Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer].
    Polevaia EB; Tkacheva GA; Ivanov VM; Koposova TL
    Vopr Onkol; 1984; 30(3):9-13. PubMed ID: 6710954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A preliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms.
    Menendez-Botet CJ; Oettgen HF; Pinsky CM; Schwartz MK
    Clin Chem; 1978 Jun; 24(6):868-72. PubMed ID: 657473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical significance of serum tissue polypeptide antigen as a tumor marker for urogenital carcinomas--a comparison with other tumor markers in patients with renal cell carcinoma and prostatic carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Umehara T; Ohmura K
    Hinyokika Kiyo; 1987 Oct; 33(10):1581-9. PubMed ID: 2451408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of tumor markers in breast cancer patients].
    Ito T; Tanaka S; Ban K; Sakai N; Oshita H; Oiwa T; Kanno A; Kashizuka T
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2917-23. PubMed ID: 3310907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [CEA and TPA in serum and pleural exudates in patients with pulmonary neoplasms: preliminary results].
    Iannucci F; di Matteo L; Di Martino G; Tranchese D; Auriemma L; Micillo E; Catena E
    Arch Monaldi; 1983; 38(1-2):3-8. PubMed ID: 6675556
    [No Abstract]   [Full Text] [Related]  

  • 39. Oncofetal antigen-I: distribution in human tumors.
    Rees WV; Irie RF; Morton DL
    J Natl Cancer Inst; 1981 Sep; 67(3):557-62. PubMed ID: 6268878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tumor-associated markers in malignant lung neoplasms].
    Piancino G; Racca P; Rayneri W; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1986 Jan; 77(1-2):19-25. PubMed ID: 3945411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.